Vietnamese Pharma Market Booming But "Chaotic"

28 July 1996

Major changes in the Vietnamese pharmaceutical industry over the past few years have resulted in a vast increase in the supply of medicines on the market, but consumers are said to be confused about which drugs to buy because of the huge number of different medicines on the market, particularly imports, reports the Vietnam Courier.

Most consumers choose foreign brands, even though many of these drugs have not been checked and approved by the health authorities. As a result, not only is the health of consumers threatened, but also the business of Vietnamese drugmakers.

Press sources in the capital, Hanoi, describe the state of the market as "chaos." In just a few years, the state sector's 20 drug production plants and 70 trading units have been supplemented by 160 limited liability companies and three joint stock companies. In Ho Chi Minh City alone, there are 3,000 pharmacies compared with 1,200 in 1975, as well as four drug trading centers, most of which sell mainly foreign drugs whose efficacy and safety are suspect, says the Courier.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight